Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:QTZM)

2.980 -0.200 (-6.29%)
Streaming Delayed Price Updated: 3:49 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about QTZM

< Previous 1 2 Next >
News headline image
Quantumzyme to Engage With Industry Leaders at BioLogic Summit 2026, Reinforcing Commitment to AI-Driven Innovation
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence
Quantumzyme to Engage With Industry Leaders at BioLogic Summit 2026, Reinforcing Commitment to AI-Driven Innovation
Via TheNewswire.com
Topics Artificial Intelligence
News headline image
Quantumzyme Announces Board Approval for Strategic Name Change to Quantum Genesis AI
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence
Quantumzyme Announces Board Approval for Strategic Name Change to Quantum Genesis AI
Via TheNewswire.com
Topics Artificial Intelligence
News headline image
Quantumzyme to Showcase Sustainable Enzyme Engineering Innovations at CCE-2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Quantumzyme to Showcase Sustainable Enzyme Engineering Innovations at CCE-2026
Via TheNewswire.com
News headline image
Quantumzyme Announces First Lab-Scale Sample of Green Ibuprofen Shipped for Industrial Validation
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
Quantumzyme Announces First Lab-Scale Sample of Green Ibuprofen Shipped for Industrial Validation
Via TheNewswire.com
Topics Intellectual Property
News headline image
Quantumzyme Expands AI-Driven Enzyme Engineering Platform to Broaden Green API Manufacturing Applications
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Economy Emissions
Quantumzyme Expands AI-Driven Enzyme Engineering Platform to Broaden Green API Manufacturing Applications
Via TheNewswire.com
Topics Economy Emissions
News headline image
Quantumzyme Announces Publication of Green Ibuprofen Process in RSC Sustainability
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Quantumzyme Announces Publication of Green Ibuprofen Process in RSC Sustainability
Via TheNewswire.com
Quantumzyme Announces Publication of Patents Supporting Sustainable Pharmaceutical Growth &amp; Innovation
Via TheNewswire.com
Topics Intellectual Property
News headline image
Quantumzyme Announces Publication of Patents Supporting Sustainable Pharmaceutical Growth & Innovation
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
News headline image
Quantumzyme Corp. Participated in Enzyme Engineering XXVIII Conference in Denmark
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence Intellectual Property
Quantumzyme Corp. Participated in Enzyme Engineering XXVIII Conference in Denmark
Via TheNewswire.com
Topics Artificial Intelligence Intellectual Property
News headline image
Quantumzyme Corp. Announces USPTO Publication of Breakthrough Ibuprofen Patent
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
Quantumzyme Corp. Announces USPTO Publication of Breakthrough Ibuprofen Patent
Via TheNewswire.com
Topics Intellectual Property
Quantumzyme Announces Removal of OTC Markets Caveat Emptor Designation
Via TheNewswire.com
News headline image
Quantumzyme Announces Removal of OTC Markets Caveat Emptor Designation
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Quantumzyme Responds to OTC Markets Caveat Emptor Designation and Denounces Unauthorized Promotion Activity
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Quantumzyme Responds to OTC Markets Caveat Emptor Designation and Denounces Unauthorized Promotion Activity
SAN DIEGO, CA - April 30, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, today announced that it is in contact with OTC... 
Via TheNewswire.com
News headline image
Quantumzyme Highlights Benefits and Commercialization Opportunities of Pending Breakthrough Green Chemistry Patent
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence Intellectual Property
Quantumzyme Highlights Benefits and Commercialization Opportunities of Pending Breakthrough Green Chemistry Patent
SAN DIEGO, CA - April 28, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, is pleased to announce the key benefits and... 
Via TheNewswire.com
Topics Artificial Intelligence Intellectual Property
News headline image
Quantumzyme Anticipates Publication of Transformative Patent for Enzymatic Ibuprofen Manufacturing
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
Quantumzyme Anticipates Publication of Transformative Patent for Enzymatic Ibuprofen Manufacturing
SAN DIEGO, CA - April 23, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, is pleased to announce the upcoming publication of... 
Via TheNewswire.com
Topics Intellectual Property
News headline image
Quantumzyme Highlights Enzyme Engineering Platform and Ongoing Work in Sustainable Ibuprofen Synthesis
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Quantumzyme: Advancing Enzymatic Innovation for a Sustainable Industrial Future
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence
News headline image
Quantumzyme Introduces Manu Bharath Khareedhi as Independent Director, Looks to Strengthen Strategic Growth and Innovation
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Quantumzyme Introduces Manu Bharath Khareedhi as Independent Director, Looks to Strengthen Strategic Growth and Innovation
SAN DIEGO, CA - April 8, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC:QTZM), a pioneering biotechnology company specializing in computational enzyme engineering, is pleased to introduce Manu Bharath... 
Via TheNewswire.com
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.